PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
31.40%
Revenue growth at 50-75% of PONY's 53.48%. Martin Whitman would worry about competitiveness or product relevance.
-10.09%
Negative gross profit growth while PONY is at 49.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
138.46%
Positive operating income growth while PONY is negative. John Neff might view this as a competitive edge in operations.
151.67%
Positive net income growth while PONY is negative. John Neff might see a big relative performance advantage.
151.78%
Positive EPS growth while PONY is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
151.78%
Positive diluted EPS growth while PONY is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.01%
Share reduction more than 1.5x PONY's 4.32%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.14%
Negative OCF growth while PONY is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-86.89%
Negative FCF growth while PONY is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-67.50%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-62.33%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-78.61%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-77.79%
Negative 10Y OCF/share CAGR while PONY stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-80.81%
Negative 5Y OCF/share CAGR while PONY is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
107.75%
3Y OCF/share CAGR of 107.75% while PONY is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-90.66%
Negative 10Y net income/share CAGR while PONY is at 63.21%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-85.69%
Negative 5Y net income/share CAGR while PONY is 63.21%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
408.55%
3Y net income/share CAGR above 1.5x PONY's 63.21%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
35.33%
Below 50% of PONY's 132.50%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-3.60%
Negative 5Y equity/share growth while PONY is at 132.50%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-5.94%
Negative 3Y equity/share growth while PONY is at 132.50%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while PONY stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while PONY invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
7.33%
AR growth well above PONY's 14.29%. Michael Burry fears inflated revenue or higher default risk in the near future.
-41.82%
Inventory is declining while PONY stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.13%
Asset growth above 1.5x PONY's 1.92%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
0.62%
Positive BV/share change while PONY is negative. John Neff sees a clear edge over a competitor losing equity.
-65.57%
We’re deleveraging while PONY stands at 38.45%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while PONY invests at 3.25%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-26.11%
We cut SG&A while PONY invests at 44.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.